Two foreign vaccine firms faces penalty for false ads

Published: 2004-11-16 07:00:00

Updated: 2004-11-16 07:00:00

The Korea Food and Drug Administration said on November 11 that it is considering taking administrative measures to deal with two foreign-invested pharmaceutical firms, GlaxoSmithKline (GSK) and Sanofi-Aventis Korea, and will pose a certain amount of fines for falsely advertising their vaccine pr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK